Citation Impact
Citing Papers
The nuclear receptor REV-ERBα mediates circadian regulation of innate immunity through selective regulation of inflammatory cytokines
2011
Treatment of non-steroidal anti-inflammatory drug induced enteropathy.
1990
The risk of colorectal cancer in ulcerative colitis: a meta-analysis
2001 Standout
Intracellular Nucleic Acid Sensors and Autoimmunity
2011 StandoutNobel
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2012 Standout
FRAX™ and the assessment of fracture probability in men and women from the UK
2008 Standout
The clinician’s guide to prevention and treatment of osteoporosis
2022
[Leptin: a link between obesity and osteoarthritis?].
2004
Clinician’s Guide to Prevention and Treatment of Osteoporosis
2014 Standout
Association of IFIH1 rs1990760 polymorphism with susceptibility to autoimmune diseases: A meta-analysis
2013
EULAR recommendations for the management of primary small and medium vessel vasculitis
2008 Standout
Osteoporosis
2019 Standout
Oxidative stress, aging, and diseases
2018 Standout
Rheumatoid arthritis
2018 Standout
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Osteoprotegerin protects against generalized bone loss in tumor necrosis factor–transgenic mice
2003
Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis
2007
A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis1
2002
The human selenoproteome: recent insights into functions and regulation
2009
Study of Transcriptional Effects in Cis at the IFIH1 Locus
2010
SKG arthritis as a model for evaluating therapies in rheumatoid arthritis with special focus on bone changes
2012 StandoutNobel
Vertebral Fracture Assessment: The 2005 ISCD Official Positions
2006
BONE LOSS AND FRACTURE AFTER LUNG TRANSPLANTATION1
1999
Juvenile idiopathic arthritis
2007 Standout
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice
2009
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Desensitization to allopurinol in patients with gout and cutaneous reactions
1992
Risk factors for colorectal cancer in patients with ulcerative colitis: A case-control study
1994
Assessment of hand trabecular bone texture with high resolution direct digital radiograph in rheumatoid arthritis: A case control study
2011
A UK Consensus Group on management of glucocorticoid‐induced osteoporosis: an update
1998
TNF superfamily in inflammatory disease: translating basic insights
2011
Effective Doses in Radiology and Diagnostic Nuclear Medicine: A Catalog
2008 Standout
Selenium and human health
2012 Standout
Sulfasalazine in the treatment of juvenile chronic arthritis: A randomized, double-blind, placebo-controlled, multicenter study
1998
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
2006 Standout
Genetics and epigenetics of rheumatoid arthritis
2013
ACG Clinical Guidelines: Diagnosis and Management of Celiac Disease
2013 Standout
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT)
2006 Standout
Sulfasalazine in the treatment of spondylarthropathy
1995
Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin
1999
Skeletal remodeling in health and disease
2007 Standout
Role of proinflammatory cytokines in the pathophysiology of osteoarthritis
2010 Standout
The Epidemiology of Distal Radius Fractures
2012 Standout
Mechanisms involved in the side effects of glucocorticoids
2002 Standout
Genetic susceptibility to rheumatoid arthritis: An emerging picture
2009
Osteoporosis in inflammatory joint diseases
2010
Circadian control of the immune system
2013 Standout
Ankylosing spondylitis
2007 Standout
Recent progress in rheumatoid arthritis genetics: one step towards improved patient care
2009
Prevalence of Reduced Bone Mineral Density in Patients with Anti-neutrophil Cytoplasmic Antibody Associated Vasculitis and the Role of Immunosuppressive Therapy: A Cross-Sectional Study
2002
The Epidemiology of Serious Adverse Drug Reactions Among the Elderly
1999
Molecular mechanisms of T cell co-stimulation and co-inhibition
2013 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors
2011 Standout
Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy
2003
What old means to bone
2010 Standout
PTPN2 links colonic and joint inflammation in experimental autoimmune arthritis
2020 StandoutNobel
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
Severe Adverse Cutaneous Reactions to Drugs
1994 Standout
Rheumatoid arthritis
2010 Standout
Reduced Expression of IFIH1 Is Protective for Type 1 Diabetes
2010
Regulation of type I interferon responses
2013 Standout
Allopurinol Sensitivity in a Patient With Chronic Tophaceous Gout: Success of Intravenous Desensitization After Failure of Oral Desensitization
1991
Targeting ferroptosis as a vulnerability in cancer
2022 Standout
STOPP/START criteria for potentially inappropriate prescribing in older people: version 2
2014 Standout
An update on the pathophysiology of osteoarthritis
2016 Standout
Radiation exposure in bone mineral density assessment
1999
Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritis
2008
Efficacy and safety of desensitization to allopurinol following cutaneous reactions
2001
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Genetic predisposition to autoimmunity – What have we learned?
2011
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Glucocorticoids Act Directly on Osteoblasts and Osteocytes to Induce Their Apoptosis and Reduce Bone Formation and Strength
2003
Risk of fractures in celiac disease patients: a cross-sectional, case-control study
2000
Disorders Associated With Acute Rapid and Severe Bone Loss
2003
Sulfasalazine
2005
Polymorphisms in melanoma differentiation‐associated gene 5 link protein function to clearance of hepatitis C virus
2014 StandoutNobel
B7x in the Periphery Abrogates Pancreas-Specific Damage Mediated by Self-reactive CD8 T Cells
2012 StandoutNobel
Genetics of Kawasaki Disease
2012
Prevalence and determinants of osteoporosis drug prescription among patients with high exposure to glucocorticoid drugs.
2001
Low dose glucocorticoids in early rheumatoid arthritis.
2004
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis*
2000 Standout
Direct and metabolism‐dependent toxicity of sulphasalazine and its principal metabolites towards human erythrocytes and leucocytes.
1991
Management of Rheumatoid Arthritis: Rationale for the Use of Colloidal Metallic Gold
1997
From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of Osteoporosis
2010 Standout
A Review of Activity Indices and Efficacy End Points for Clinical Trials of Medical Therapy in Adults With Ulcerative Colitis
2006 Standout
Corticosteroids and Fractures: A Close Encounter of the Third Cell Kind
2000
Long-term anti-arthritic and anti-osteoporotic effects of raloxifene in established experimental postmenopausal polyarthritis
2008
Inflammation and Cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation
2004 Standout
Works of D E Bax being referenced
The interferon induced with helicase domain 1 A946T polymorphism is not associated with rheumatoid arthritis
2007
A gain of function polymorphism in the interleukin 6 receptor influences RA susceptibility
2009
Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13
2008
Combined effects of three independent SNPs greatly increase the risk estimate for RA at 6q23
2009
Bone mineral density of the hand in rheumatoid arthritis
1994
Association of CD40 with rheumatoid arthritis confirmed in a large UK case-control study
2009
LEUCOPENIA IN RHEUMATOID ARTHRITIS: RELATIONSHIP TO GOLD OR SULPHASALAZINE THERAPY
1988
Evidence of epistasis between interleukin 1 and selenoprotein-S with susceptibility to rheumatoid arthritis
2008
Prevention of Bone Loss with Risedronate in Glucocorticoid-Treated Rheumatoid Arthritis Patients
2000
Therapeutic Audit on A General Medical Ward
1987
Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis.
1995
Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years.
1986
Sulphasalazine in rheumatoid arthritis: desensitising the patient with a skin rash.
1986
A double-blind, placebo-controlled study to determine the effects of risedronate on bone loss in glucocorticoid-treated rheumatoid arthritis patients
1996
Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate.
1985